Polymorphisms of the endothelial nitric oxide synthase gene - No consistent association with myocardial infarction in the ECTIM study

European Journal of Clinical Investigation

Volumn 29, Issue 4, 1999, Pages 284-290

  Poirier, O ^f   Mao, C ^f   Mallet, C ^f   Nicaud, V ^f   Herrmann, S M ^f   Evans, A ^a   Ruidavets, J B ^b   Arveiler, D ^c   Luc, G ^d   Tiret, L ^f   Soubrier, F ^f   Cambien, F ^e  

^a MONICA Project   (United Kingdom)

^b MONICA Project   (France)

^c MONICA Project   (France)

^d MONICA Project   (France)

^e INSERM   (France)

^f NONE

Author keywords

Endothelial nitric oxide synthase gene; Gene polymorphisms; Myocardial infarction

Indexed keywords

NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; DNA FLANKING REGION; DNA POLYMORPHISM; ENDOTHELIUM; GENOTYPE; HEART INFARCTION; HUMAN; INTRON; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; DNA PRIMERS; FRANCE; GENE FREQUENCY; GENETIC SCREENING; GENOTYPE; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NORTHERN IRELAND; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RISK FACTORS;

EID: 0000164602     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00451.x     Document Type: Article

References (29)

1. 1 Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2: 1057-8.
2. 2 Vanhoutte PM. Endothelial dysfunction and atherosclerosis. Eur Heart J 1997; 18 (Suppl. E):E19-E29.
3. 3 Taddei S, Virdis A, Mattei P, et al. Ageing and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 1995; 91: 1981-7.
4. 4 Cox DA, Vita JA, Treasure CB, et al. Atherosclerosis impairs flow-mediated ilation of coronary arteries in humans. Circulation 1989; 80: 458-65.
5. 5 Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-7.
6. 6 Stehouwer CD, Lambert J, Donker AJ, van Hinsbergh VW. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997; 34: 55-68.
7. 7 Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Circulation 1992; 85: 1927-38.
8. 8 Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.
9. 9 Wang XL, Mahaney MC, Sim AS, et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997; 17: 3147-53.
10. 10 Miyahara K, Kawamoto T, Sase K, et al. Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur J Biochem 1994; 223: 719-26.
11. 11 Zhang R, Min W, Sessa WC. Functional analysis of the human endothelial nitric oxide synthase promoter. J Biol Chem 1995; 270: 15320-6.
12. 12 Janssens SP, Shimouchi A, Quetermous T, Bloch DB, Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992; 267: 14519-22.
13. 13 Nadaud S, Bonnardeaux A, Lanthrop M, Soubrier F. Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1994; 198: 1027-33.
14. 14 Marsden PA, Heng HH, Scherer SW, et al. Structure and chromosomal localisation of the, human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-88.
15. 15 Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DEL. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med 1996; 2: 41-5.
16. 16 Ichihara S, Yamada Y, Fujimara T, Nakashima N, Yokota M. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 1998; 81: 83-6.
17. 17 Parra HJ, Arveiler D, Evans AE, et al. A case-control study of lipoprotein particles in two populations at contrasting risk for CHD, the ECTIM Study. Arteriosclerosis Thromb 1992; 12: 701-7.
18. 18 Bonnardeaux A, Nadaud S, Charru A, Jeunemaitre X, Corvol P, Soubrier F. Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation 1995; 91: 96-102.
19. 19 Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphism. Proc Natl Acad Sci USA 1989; 86: 2766-70.
20. 20 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-7.
21. 21 Saiki RK. Genetic analysis of enzymatically amplified β-globin and HLA-DQA genomic DNA with allele specific oligonucleotide probes. Nature 1987; 324: 163-6.
22. 22 Tiret L, Amouyel P, Rakotouao R, Cambien F, Ducimetiere P. Testing for association between disease and linked matter loci - a log-linear model analysis. Am J Hum Genet. 1991; 48: 926-34.
23. 23 Liu K, Bai H, Saku K, Hiroki T, Arakawa K. A missense mutation of the eNOS gene in patients with coronary heart disease and its possible interaction with ACE I/D gene for coronary risk (Abstract). J Am Coll Cardiol 1997; 29 (Suppl. A):123A.
24. 24 Hibi K, Ishigami T, Tamura K, et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998; 32: 521-6.
25. 25 Shimasaki Y, Yasue H, Yoshimura M, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998; 31: 1506-10.
26. 26 Markus HS, Ruigrok Y, Ali N, Powell JF. Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma. Stroke 1998; 29: 1908-11.
27. 27 Yasue H, Yoshimura M, Sigiyama S, et al. Association of a point mutation of the endothelial cell nitric oxide synthase (eNOS) gene with coronary spasm (Abstract). Circulation 1995; 92 (Suppl. 1): I-363.
28. 28 Yasue H, Nakayama M, Yoshimura M, et al. The A to G mutation at nucleotide position -924 in the endothelial nitric oxide synthase gene positively associated with coronary spastic angina (Abstract). Circulation 1996; 94 (Suppl. 1):146.
29. -786C mutation reduces promoter activity in the endothelial nitric oxide synthase gene and is associated with coronary spasm (Abstract). Circulation 1997; 96 (Suppl. 1): 1-315.